Searched for
POTENTIAL ANTIVIRAL DRUGS
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Companies stare at huge losses as unsold Covid drugs pile upDuring the past two years, there were sky-rocketing sales of Covid-19 portfolio of drugs, sometimes even severe shortages. But now the indu...
- B'luru firm Bugworks begins work on drug against Covid-type virusesThe hunt for safe and effective Covid antivirals that can be used against Covid is on. Currently Pfizer's Paxlovid and MSD-Ridgeback Biothe...
- New antiviral drug combo highly effective against COVID-19: Study"Identifying combinations of antivirals is really important, not only because doing so may increase the drugs' potency against the coronavi...
- US nod in Hand, Pfizer is looking for partners to make Covid drug in IndiaThe company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of maki...
- Pfizer pill becomes 1st US-authorized home COVID treatmentData from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...
- Merck v Pfizer: here's how the two new COVID antiviral drugs work and will be usedUK approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. Now, Pfizer has released results from trials o...
- Local firms gear up to seek licence for Pfizer's Covid drugUS drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...
- Indian pharma eyes affordable antiviral medicines to treat Covid-19The coronavirus is headed to the endemic stage in certain countries, giving these new drugs a potentially huge market, along with the abili...
- Pfizer enters deal with UN-backed MPP to license COVID drug in 95 countries including IndiaPfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...
- Pfizer's pill is the latest COVID treatment to show promise. Here are some moreAccording to Pfizer's trial results, Paxlovid could be used as an alternative to in-hospital treatment for preventing disease progression i...
- Remdesivir, hydroxychloroquine show no antiviral effect against COVID-19: StudyThe study, published in the journal Annals of Internal Medicine, evaluated the effects of the two drugs on all-cause, in-hospital mortality...
- New post-infection treatment for COVID-19 identifiedThese protease inhibitors are a class of antiviral drugs that prevent viral reproduction by selectively binding to viral enzymes and blocki...
- Pfizer begins early-stage study of oral drug to combat coronavirusThe drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's BioNTech SA, said the antiviral candidate s...
- Potential antiviral drug against Covid-19 identified, scientists say it's 'highly effective'It triggers a response against three major types of human respiratory viruses, including Covid.
- Dr Reddy’s inks licensing pact with Gilead for Remdesivir to treat Covid-19The Hyderabad headquartered drug maker will obtain technology transfer from Gilead for manufacturing of the drug wherein the Indian firm wo...
- Indian-origin scientist identifies four possible drugs to treat COVID-19The study, published in the journal Pathogens, found that all four drugs were effective in inhibiting, or blocking, the coronavirus' RNA pr...
Load More
